Peripheral naïve CD8+ T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study

by Cheng Huang, Bin Xu, Xiao‐Dong Zhu, Ying‐Hao Shen, Mei‐Ling Li, Jin‐Jin Zhu, Jian Zhou, Jia Fan, Hui‐Chuan Sun
Published 2022-11-01

Criteria for identifying potentially resectable patients with initially oncologically unresectable hepatocellular carcinoma before treatment with lenvatinib plus an anti–PD–1 antib...

by Bin Xu, Xiao-Dong Zhu, Ying-Hao Shen, Jin-Jin Zhu, Jie Liu, Mei-Ling Li, Pei-Wen Tang, Jian Zhou, Jia Fan, Hui-Chuan Sun, Cheng Huang
Published 2022-11-01

Treatment With Liraglutide Exerts Neuroprotection After Hypoxic–Ischemic Brain Injury in Neonatal Rats via the PI3K/AKT/GSK3β Pathway

by Shan-shan Zeng, Jun-jie Bai, Huai Jiang, Jin-jin Zhu, Chang-chang Fu, Min-zhi He, Jiang-hu Zhu, Shang-qin Chen, Pei-jun Li, Xiao-qin Fu, Zhen-lang Lin
Published 2020-01-01

Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations

by Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, Yuan Ji, Ning-Ling Ge, Xu-Dong Qu, Lingli Chen, Wen-Kai Shi, Mei-Ling Li, Jin-Jin Zhu, Chang-Jun Tan, Zhao-You Tang, Jian Zhou, Jia Fan, Hui-Chuan Sun
Published 2021-03-01